ScoreWhy is Relay Therapeutics, Inc. ?
1
Flat results in Jun 25
- NET SALES(HY) At USD 8.36 MM has Grown at -16.5%
- ROCE(HY) Lowest at -46.24%
- RAW MATERIAL COST(Y) Grown by 4,801% (YoY)
2
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 65.64%, its profits have fallen by -2.5%
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating Performance
- The stock has generated a return of 65.64% in the last 1 year, much higher than market (S&P 500) returns of 12.33%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Relay Therapeutics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Relay Therapeutics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Relay Therapeutics, Inc.
82.23%
0.09
78.37%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
56.41%
EBIT Growth (5y)
-206.44%
EBIT to Interest (avg)
-283.27
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.98
Sales to Capital Employed (avg)
0.02
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.80
EV to EBIT
0.34
EV to EBITDA
0.34
EV to Capital Employed
-7.71
EV to Sales
-16.72
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-47.81%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
OPERATING PROFIT(Q)
Highest at USD -75.84 MM
PRE-TAX PROFIT(Q)
Highest at USD -70.38 MM
NET PROFIT(Q)
Highest at USD -70.38 MM
EPS(Q)
Highest at USD -0.41
-7What is not working for the Company
NET SALES(HY)
At USD 8.36 MM has Grown at -16.5%
ROCE(HY)
Lowest at -46.24%
RAW MATERIAL COST(Y)
Grown by 4,801% (YoY
Here's what is working for Relay Therapeutics, Inc.
Operating Profit
Highest at USD -75.84 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD -70.38 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -70.38 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.41
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Here's what is not working for Relay Therapeutics, Inc.
Net Sales
At USD 8.36 MM has Grown at -16.5%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Raw Material Cost
Grown by 4,801% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
